Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Xencor, Inc.
Xencor, Inc.
Nuvectis Pharma, Inc.
Pfizer
Tizona Therapeutics, Inc
Essen Biotech
A2 Biotherapeutics Inc.
University of Nebraska
Takeda
Kidney Cancer Research Bureau
Adela, Inc
Second Life Therapeutics
Elephas
Novartis
Kura Oncology, Inc.
Harvard Medical School (HMS and HSDM)
Elephas